Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope

Metabolism: Clinical and Experimental

Volumn 52, Issue 3, 2003, Pages 315-321

  Bondanelli, Marta ^a,b,c   Alboni, Paolo ^a,b,c   Margutti, Angelo ^a,b,c   Franceschetti, Paola ^a,b,c   Dinelli, Maurizio ^a,b,c   Gruppillo, Paolo ^a,b,c   Marchi, Paola ^a,b,c   Degli Uberti, Ettore C ^a,b,c  

^a UNIVERSITY OF FERRARA   (Italy)

^b Ospedale di Cento Fe   (Italy)

^c S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; GALANIN; NORADRENALIN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANAMNESIS; ARTICLE; CARDIOVASCULAR PARAMETERS; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEAD TILTING; HEART RATE; HUMAN; MALE; PLASMA; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SUPINE POSITION; SYNCOPE; SYSTOLIC BLOOD PRESSURE; UNCONSCIOUSNESS;

EID: 0037354283     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50051     Document Type: Article

References (40)

1. Fenton AM, Hammil SC, Rea R, et al: Vasovagal syncope. Ann Intern Med 133:714-725, 2000
2. Mosqued-Garcia R, Furlan R, Tank J, et al: The elusive pathophysiology of neurally mediated syncope. Circulation 102:2898-2906, 2000
3. Grubb BP, Kosinski DJ: Serotonin and syncope: An emerging connection? Eur J Cardiac Pacing Electrophysiol 5:306-313, 1995
4. Theodorakis GN, Markianos M, Zarvalis E, et al: Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syncope. J Am Coll Cardiol 36:174-178, 2000
5. Wallbridge DR, MacIntyre HE, Gray CE, et al: Increase in plasma beta endorphins precedes vasodepressor syncope. Br Heart J 71:597-599, 1994
6. Dietz NM, Halliwill JR, Spielmann JM, et al: Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol 82:1785-1793, 1997
7. Jardine DL, Melton IC, Crozier IG, et al: Neurohormonal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 79:1302-1306, 1997
8. Mittal S, Stein KM, Markowitz SM, et al: Induction of neurally mediated syncope with adenosine. Circulation 99:1318-1324, 1999
9. Rokaeus A: Galanin, a newly isolated biological active neuropeptide. Trends Neurosci 10:158-164, 1987
10. Michener SR, Aimone LD, Yaksh TL, et al: Distribution of galanin-like immunoreactivity in the pig, rat and human central nervous system. Peptides 11:1217-1223, 1990
11. Vrontakis ME, Torsello A, Friesen HG: Galanin. J Endocrinol Invest 14:785-794, 1991
12. Giustina A, Veldhuis JD: Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and humans. Endocrine Rev 19:717-797, 1998
13. Giustina A, Licini M, Schettino M, et al: Physiological role of galanin in the regulation of anterior pituitary function in humans. Am J Physiol 266:E57-E61, 1994
14. Crawley JN: The role of galanin in feeding behavior. Neuropeptides 33:369-375, 1999
15. Diaz-Cabiale Z, Narvaez JA, Yanaihara N, et al: Galanin/alpha2-receptor interactions in central cardiovascular control. Neuropharmacology 39:1377-1385, 2000
16. Hökfelt T, Xu ZQD, Shi TJ, et al: Galanin in ascending systems: Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann NY Acad Sci 863:252-263, 1998
17. Ulman LG, Evans HF, Iismaa TP, et al: Effect of human, rat and porcine galanins on cardiac vagal action and blood pressure in the anaesthetized cat. Neurosci Lett 136:105-108, 1992
18. Shih CD, Chan SHH, Chan JYH: Participation of endogenous galanin in the suppression of baroreceptor reflex response by locus coeruleus in the rat. Brain Res 721:76-82, 1997
19. Degli Uberti EC, Ambrosio MR, Bondanelli M, et al: Human galanin reduces plasma norepinephrine levels in man. J Clin Endocrinol Metab 80:1894-1898, 1995
20. Degli Uberti EC, Ambrosio MR, Bondanelli M, et al: Effect of human galanin on the response of circulating catecholamines to hypoglycemia in man. Eur J Endocrinol 133:723-728, 1995
21. Degli Uberti EC, Bondanelli M, Margutti A, et al: The acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide. Neuroendocrinology 64:398-404, 1996
22. Brignole M, Alboni P, Benditt D, et al: Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1156-1306, 2001
23. Kenny RA, Bayliss J, Jngram A, et al: Head up tilt test: A useful test for investigating unexplained syncope. Lancet 1:1352-1354, 1986
24. Sutton R, Petersen M, Brignole M, et al: Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 3:180-183, 1992
25. Matzen SH: Neuroendocrine mechanisms during reversible hypovolemic shock in humans with emphasis on the hystaminergic and serotonergic system. Acta Physiol Scand 628:6-31, 1995 (suppl)
26. Smith GDP, Watson LP, Mathias CJ: Cardiovascular and catecholamine changes induced by supine exercise and upright posture in vasovagal syncope: Comparison with normal subjects and subjects with sympathetic denervation. Eur Heart J 17:1882-1890, 1996
27. Shen WK, Low PA, Rea RF, et al: Distinct hemodynamic profiles in patients with vasovagal syncope: A heterogeneous population. J Am Coll Cardiol 35:1470-1477, 2000
28. Dunning BE, Havel PJ, Veith RC, et al: Pancreatic and extrapancreatic galanin release during sympathetic neural activation. Am J Physiol 258:E436-E444, 1990
29. Havel PJ, Mundinger TO, Veith RC, et al: Corelease of galanin and NE from pancreatic sympathetic nerves during severe hypoglycemia in dogs. Am J Physiol 263:E8-E16, 1992
30. Yuan C-S, Xie J-T, Aung HH: Gastric effects of galanin and its interaction with leptin on brainstem neuronal activity, J Pharmacol Exp Ther 301:488-493, 2002
31. Giustina A, Brogan R, Conley L, et al: Acute and chronic galanin administration decreased hypothalamic galanin synthesis in both male and female adult rats: Evidence for a long-loop galanin autofeedback. Metabolism 49:778-783, 2000
32. Carey DG, Iismaa TP, Ho KY, et al: Potent effects of human galanin in man: Growth hormone secretion and vagal blockade. J Clin Endocrinol Metab 77:90-93, 1993
33. Potter E: Cardiovascular actions of galanin. Ann NY Acad Sci 863:170-174, 1998
34. Mundinger TO, Taborsky GJ Jr: Differential action of hepatic sympathetic neuropeptides: Metabolic action of galanin, vascular action of NPY. Am J Physiol Endocrinol Metab 278:E390-E397, 2000
35. Houston DS, Vanhoutte PM: Serotonin and the vascular system: Role in health and disease, implications for therapy. Drugs 31:149-163, 1986
36. A receptor agonists on sympathetic and parasympathetic nerve activity. J Cardiovasc Pharmacol 15:75-85, 1990 (suppl 7)
37. Theodorakis GN, Markianos M, Livanis EG, et al: Central serotonergic responsiveness in neurocardiogenic syncope: A clomipramine test challenge. Circulation 98:2724-2730, 1998
38. 1A receptor interactions in the brain. Ann NY Acad Sci 863:274-290, 1998
39. Örgen SO, Schott PA, Kehr J, et al: Modulation of acetylcholine and serotonin transmission by galanin: Relationship to spatial and adversive learning. Ann NY Acad Sci 863:342-363, 1998
40. Alboni P, Bondanelli M, Dinelli M, et al: Role of serotonergic system in the genesis of vasovagal system. Europace 2:172-180, 2000